Our 1st newsletter highlights breakthroughs in cancer care—from liquid biopsies advancing early detection to PARP inhibitors in prostate cancer. Don’t miss Emily Whitehead’s inspiring CAR T-cell therapy story, marking a new era in immunotherapy.

In this 2nd edition, we share expert consensus on bone health in prostate cancer, highlights from St. Gallen/Vienna 2025 on early breast cancer therapies, and a review of AI in monitoring neoadjuvant treatment. Together, these reflect evolving strategies and innovations shaping oncology’s future."